FEDERICO
PULIDO ORTEGA
Profesor asociado de Ciencias de la Salud
Miguel
Torralba González de Suso
Publicaciones en las que colabora con Miguel Torralba González de Suso (10)
2021
-
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study
BMC Infectious Diseases, Vol. 21, Núm. 1
2020
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2016
-
Executive summary: Prevención y tratamiento de infecciones oportunistas y otras coinfecciones en pacientes infectados por el VIH: mayo de 2015
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 8, pp. 517-523
-
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 8, pp. 516.e1-516.e18
2004
-
Clinical, Virologic, and Immunologic Response to Efavirenz- or Protease Inhibitor-Based Highly Active Antiretroviral Therapy in a Cohort of Antiretroviral-Naive Patients with Advanced HIV Infection (EfaVIP 2 Study)
Journal of Acquired Immune Deficiency Syndromes, Vol. 35, Núm. 4, pp. 343-350
2002
-
Estudio epidemiológico retrospectivo sobre la duración del tratamiento de la infección por el virus de la inmunodeficiencia humana en España
Medicina Clinica, Vol. 119, Núm. 19, pp. 721-724
-
High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/μl and opportunistic diseases: The Efa VIP study (Efavirenz in very immunosuppressed patients)
AIDS, Vol. 16, Núm. 11, pp. 1554-1556
-
Lipid changes in HIV-infected patients who started rescue therapy with an amprenavir/ritonavir-based highly active antiretroviral therapy [3]
AIDS
-
NNRTI hepatotoxicity: efavirenz versus nevirapine.
Journal of HIV therapy, Vol. 7 Suppl 2
2001
-
Efficacy and toxicity of treatment with efavirenz or indinavir plus zidovudine and lamivudine: An approach according to evidence-based medicine
Enfermedades Emergentes, Vol. 3, Núm. 1, pp. 28-32